TransMedics menetapkan prospek pendapatan 2026 sebesar $737 juta-$757 juta sembari menargetkan 30.000 transplantasi pada 2032 (NASDAQ:TMDX)
· seekingalpha.com
Sorotan panggilan pendapatan Q2 2026 TransMedics (TMDX): rekor pendapatan $190 juta, peningkatan panduan 2026, prospek margin, dilusi PAD, dan katalis—baca sekarang.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...